Setting of Methods for Analysis of Mucosal Antibodies in Seminal and Vaginal Fluids of HIV Seropositive Subjects from Cambodian and Italian Cohorts
暂无分享,去创建一个
L. Lopalco | G. Corrao | L. Scotti | G. Pancino | A. Zambon | L. Diomede | Cinzia Bisighini | D. Ferrari | J. Nouhin | G. Gallotta | C. Donadoni | M. Ngyen | Lucia DeSantis
[1] R. Detels. The 'immunologic advantage' of HIV-exposed seronegative individuals , 2009 .
[2] J. Fahey,et al. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. , 2008, AIDS.
[3] J. Mestecky,et al. Neutralizing antibodies in mucosal secretions: IgG or IgA? , 2007, Current HIV research.
[4] J. Mestecky. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. , 2006, Journal of reproductive immunology.
[5] T. Lehner,et al. Innate and Adaptive Mucosal Immunity in Protection against HIV Infection , 2006, Advances in dental research.
[6] J. Mestecky,et al. Human Male Genital Tract Secretions: Both Mucosal and Systemic Immune Compartments Contribute to the Humoral Immunity1 , 2005, The Journal of Immunology.
[7] T. Quinn,et al. HIV/AIDS in Women: An Expanding Epidemic , 2005, Science.
[8] A. Trkola,et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies , 2005, Nature Medicine.
[9] M. Mulligan,et al. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. , 2004, AIDS research and human retroviruses.
[10] L. Lopalco,et al. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. , 2004, Blood.
[11] L. Lopalco. Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance? , 2004, Current HIV research.
[12] P. Reichelderfer,et al. Recent observations on HIV type-1 infection in the genital tract of men and women. , 2003, AIDS.
[13] P. Goepfert,et al. Detection of mucosal antibodies in HIV type 1-infected individuals. , 2002, AIDS research and human retroviruses.
[14] R. Lynch,et al. Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1 , 2002, The Journal of Immunology.
[15] A. Lackner,et al. The mucosal immune system: primary target for HIV infection and AIDS. , 2001, Trends in immunology.
[16] H. Katinger,et al. Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
[17] L. Lopalco,et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate , 2000, AIDS.
[18] T. D. Pack,et al. Purification of Human IgA , 2000, Current protocols in immunology.
[19] R. Lynch,et al. Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. , 2000, Journal of acquired immune deficiency syndromes.
[20] J. Mestecky,et al. False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens. , 2000, AIDS research and human retroviruses.
[21] M. Kazatchkine,et al. An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease. , 2000, Journal of immunological methods.
[22] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[23] M. Bomsel,et al. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. , 1999, The Journal of infectious diseases.
[24] Peter H. Westfall,et al. Multiple Testing of General Contrasts Using Logical Constraints and Correlations , 1997 .
[25] L. Bergmeier,et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. , 1992, Science.
[26] R. Arnold,et al. Separation of human IgA1 and IgA2 using jacalin-agarose chromatography. , 1987, Journal of immunological methods.
[27] B Guss,et al. Structure of the IgG‐binding regions of streptococcal protein G. , 1986, The EMBO journal.
[28] S. Sirisinha,et al. Degradation of immunoglobulins by secretions of human reproductive tracts. , 1974, Journal of reproduction and fertility.
[29] R. Gnanadesikan,et al. Probability plotting methods for the analysis of data. , 1968, Biometrika.
[30] R. Detels. The 'immunologic advantage' of HIV-exposed seronegative individuals. , 2009, AIDS.
[31] K. Tanzawa,et al. BIOLOGICAL ACTIVITIES , 2006 .
[32] K. Mostov,et al. Chapter 12 – Immunoglobulin Transport and the Polymeric Immunoglobulin Receptor , 2005 .